VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CLXThe Clorox Company
$97.09$11.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCLXCash Flow

The Clorox Company (CLX) Cash Flow Statement

30Y historyFree accessUpdated daily

Cash generation is increasingly inconsistent, highlighted by a negative OCF/NI ratio of -0.65 and a free cash flow margin that plummeted to -9.9% in 2026Q3.

CLX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97Jun'96
Cash from Operations576M981M695M1.16B786M1.28B1.55B992M974M868M778M874M767M775M612M698M819M738M730M709M522M765M899M803M876M747M658M588M312.7M362.1M406.7M
Operating CF Margin %-13.81%9.8%15.67%11.06%17.38%23%15.96%15.9%14.53%13.5%15.46%13.91%13.78%11.19%13.34%15.65%13.54%13.84%14.63%11.24%17.43%20.79%19.38%21.57%19.14%16.12%14.69%11.41%14.3%18.34%
Operating CF Growth %-141.33%41.15%-39.98%47.33%-38.4%-17.46%55.85%1.85%12.21%11.57%-10.98%13.95%-1.03%26.63%-12.32%-14.77%10.98%1.1%2.96%35.82%-31.76%-14.91%11.96%-8.33%17.27%13.53%11.9%88.04%-13.64%-10.97%39.86%
Net Income756M824M292M161M471M719M939M820M823M703M648M606M579M573M543M287M526M472M461M501M443M517M490M461M357M323M394M246M350M300M222.1M
Depreciation & Amortization226M219M235M236M224M211M180M180M166M163M165M169M180M182M178M173M185M190M205M192M188M190M197M191M190M225M201M202M137.6M126.4M116.5M
Stock-Based Compensation66M81M74M73M52M50M50M43M53M51M45M32M36M35M27M32M60M58M0000000000000
Deferred Taxes133M-18M-100M-149M5M-32M-2M-20M-23M-35M5M-16M-10M-11M-12M73M24M-1M-42M-15M-28M-45M26M100M-27M-41M-16M-29M32.2M2.1M2M
Other Non-Cash Items-438M86M435M483M133M339M30M-29M44M30M11M-26M-13M15M-44M278M40M82M52M74M129M107M106M105M152M78M18M77M-1M-6M16.1M
Working Capital Changes-173M-211M-241M354M-99M-11M349M-2M-88M-47M-96M109M-7M-23M-80M-145M-38M-82M7M-43M-210M8M91M-62M178M162M56M84M-157.7M-12M50M
Change in Receivables-216M-145M-34M-13M-84M82M-27M-32M-24M-1M-52M6M20M-10M-52M-33M-21M-10M-8M-15M-29M33M8M19M3M123M-10M24M-76M-27M27.4M
Change in Inventory53M63M55M58M-18M-282M50M-7M-21M-19M-45M-25M1M-11M1M-37M2M0-26M-8M26M-17M-35M-11M3M90M-55M40M-38.9M-24.3M-5.1M
Change in Payables-49M-124M-140M157M-47M311M291M17M-47M-34M57M93M-12M-29M10M-52M000000000000000
Cash from Investing-196M-94M-175M-223M-229M-452M-252M-196M-859M-205M-430M-106M-138M-55M-277M544M-231M-197M-1.08B-268M-161M-154M-236M-193M-109M-336M-260M-313M-310.2M-572.6M-294.7M
Capital Expenditures-196M-220M-212M-228M-251M-331M-254M-206M-194M-231M-172M-125M-138M-194M-192M-228M-203M-197M-170M-147M-180M-151M-172M-205M-177M-192M-158M-292M-247.4M-95.2M-84.8M
CapEx % of Revenue2.9%3.1%2.99%3.09%3.53%4.51%3.78%3.32%3.17%3.87%2.99%2.21%2.5%3.45%3.51%4.36%3.88%3.61%3.22%3.03%3.88%3.44%3.98%4.95%4.36%4.92%3.87%7.29%9.02%3.76%3.82%
Acquisitions0128M17M00-85M00-681M0-290M000-93M747M-19M0-913M-123M-16M0-13M00-126M-120M000-165.2M
Investments-------------------------------
Other Investing0-2M20M5M22M-36M2M10M16M26M32M19M-1M135M8M25M-11M-1M1M2M35M-3M-53M10M59M-18M18M-21M-62M-15M-44.7M
Cash from Financing578M-924M-655M-753M-689M-1.39B-523M-815M-399M-645M-316M-696M-592M-685M-321M-1.08B-706M-540M380M-456M-462M-552M-605M-617M-833M-407M-285M-245M-13.8M220.8M-158.5M
Debt Issued (Net)253M0-45M-188M-83M096M189M277M-125M126M-128M-60M-355M133M-213M-354M-323M1.44B-237M-233M1.7B-282M11M-4M-210M-78M-43M173M573M36M
Equity Issued (Net)-79M-306M1M33M-20M-802M-86M-514M-226M-108M-44M-183M-164M5M-139M-562M-70M41M-829M-36M-56M-2.19B-109M-445M-377M2M-32M31M-45M-57M-84M
Dividends Paid-602M-602M-595M-583M-571M-558M-533M-490M-450M-412M-398M-385M-368M-335M-315M-303M-282M-258M-228M-183M-173M-201M-229M-193M-196M-199M-189M-162M-132.4M-120M-110.4M
Share Repurchases-61M-332M00-25M-905M-248M-661M-271M-183M-254M-434M-260M-128M-225M-655M-150M0-868M-155M-135M-2.28B-220M-486M-412M-10M-135M-33M-109M-99M-98.1M
Other Financing1.01B-16M-16M-15M-15M-31M000000000000000132M15M10M-256M00-100M00-100K
Net Change in Cash958M-37M-161M182M-138M-555M766M-21M-287M17M19M53M30M32M8M172M-119M-8M32M-10M-101M61M60M-5M-74M-3M113M30M-13.8M220.8M-46.5M
Free Cash Flow380M761M483M930M535M945M1.29B786M780M637M606M749M629M581M420M470M616M541M560M562M342M614M727M598M699M555M500M296M65.3M266.9M321.9M
FCF Margin %5.62%10.71%6.81%12.59%7.53%12.87%19.22%12.65%12.74%10.66%10.52%13.24%11.41%10.33%7.68%8.98%11.77%9.93%10.62%11.59%7.36%13.99%16.81%14.43%17.21%14.22%12.25%7.39%2.38%10.54%14.51%
FCF Growth %-52.56%57.56%-48.06%73.83%-43.39%-26.86%64.38%0.77%22.45%5.12%-19.09%19.08%8.26%38.33%-10.64%-23.7%13.86%-3.39%-0.36%64.33%-44.3%-15.54%21.57%-14.45%25.95%11%68.92%353.29%-75.53%-17.09%41.25%
FCF per Share3.126.123.877.494.327.4210.126.065.934.844.605.644.774.373.173.404.353.843.943.652.243.433.392.712.982.322.091.230.311.271.56
FCF Conversion (FCF/Net Income)0.50x1.21x2.48x7.77x1.70x1.80x1.65x1.21x1.18x1.24x1.20x1.51x1.37x1.35x1.13x1.25x1.36x1.37x1.58x1.42x1.18x0.70x1.64x1.63x2.72x2.31x1.67x2.39x0.91x1.21x1.83x
Interest Paid097M102M99M89M89M89M87M75M78M79M104M76M129M123M131M149M161M153M000000000000
Taxes Paid0264M347M73M100M303M241M207M245M347M323M236M312M263M292M295M301M275M299M000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetAdequate
Cash FlowDeteriorating
Top Statement Risk

Volatile operating cash conversion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Earnings Quality and Cash Divergence

As reported in recent financial filings, the relationship between net income and operating cash flow has become increasingly erratic, highlighted by a negative OCF/NI ratio of -0.65 in 2026Q3, which suggests a significant disconnect between accounting profitability and the actual cash generated by core operations.

The frequent swings in the OCF/NI ratio indicate that reported net income may be heavily influenced by non-cash items or timing differences that do not translate into liquidity. Investors should monitor whether this divergence reflects structural inefficiencies in working capital management or simply the lingering impact of one-time operational disruptions.

Free Cash Flow Margin Volatility

Based on the provided quarterly data, free cash flow margins have exhibited extreme instability, plummeting to -9.9% in 2026Q3 from a peak of 16.1% in 2026Q2, which underscores the difficulty the company faces in maintaining consistent cash generation amidst fluctuating operational and capital requirements.

This trajectory suggests that the company's ability to fund its dividend and capital allocation strategy is highly sensitive to short-term operational volatility. The inability to maintain a stable FCF margin may force management to rely more heavily on external financing or balance sheet liquidity to sustain shareholder returns.

Working Capital Efficiency Under Pressure

According to the cash flow statements, working capital changes have been a persistent drag on liquidity, with a notable $127 million outflow in 2026Q1, indicating that the company is struggling to optimize its cash conversion cycle in the current retail environment.

The recurring negative working capital adjustments suggest that inventory management or collection cycles are not currently aligned with revenue recognition patterns. This trend warrants further investigation into whether the company is forced to extend credit terms to maintain market share or if inventory build-ups are becoming a structural burden.

Capital Allocation Amidst Cash Constraints

As evidenced by recent quarterly disclosures, the company has continued to prioritize dividend payments and share repurchases despite periods of negative free cash flow, such as the $165 million FCF deficit in 2026Q3, which may indicate a reliance on debt to fund shareholder returns.

The decision to maintain aggressive capital returns while operating cash flow is under pressure suggests a management commitment to shareholder yield that may be unsustainable if cash generation does not improve. Investors should monitor the sustainability of this payout policy if the current cash flow volatility persists.

CLX — Frequently Asked Questions

Quick answers to the most common questions about buying CLX stock.

How much cash does The Clorox Company (CLX) generate from operations?

The Clorox Company (CLX) generated $981.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is The Clorox Company's free cash flow?

The Clorox Company (CLX) generated $761.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is The Clorox Company's capital expenditure (CapEx)?

The Clorox Company (CLX) spent $220.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does The Clorox Company distribute cash to shareholders?

In 2025, The Clorox Company (CLX) returned $602.0M to shareholders via cash dividends and spent $332.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.